Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 29% ± 10% | |
lung | 18 studies | 49% ± 15% | |
intestine | 15 studies | 45% ± 22% | |
kidney | 9 studies | 62% ± 16% | |
brain | 8 studies | 36% ± 16% | |
eye | 8 studies | 44% ± 15% | |
liver | 8 studies | 44% ± 20% | |
lymph node | 7 studies | 49% ± 19% | |
uterus | 6 studies | 56% ± 18% | |
pancreas | 5 studies | 61% ± 21% | |
bone marrow | 5 studies | 29% ± 10% | |
placenta | 4 studies | 51% ± 22% | |
prostate | 4 studies | 66% ± 23% | |
breast | 4 studies | 60% ± 6% | |
ovary | 3 studies | 45% ± 13% | |
adrenal gland | 3 studies | 59% ± 4% | |
esophagus | 3 studies | 62% ± 15% | |
skin | 3 studies | 47% ± 6% | |
thymus | 3 studies | 67% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 19515.28 | 258 / 258 | 100% | 66.67 | 230 / 230 |
liver | 100% | 9372.59 | 226 / 226 | 100% | 63.84 | 406 / 406 |
ovary | 100% | 3815.53 | 180 / 180 | 100% | 93.51 | 430 / 430 |
stomach | 100% | 3245.09 | 359 / 359 | 100% | 85.18 | 286 / 286 |
uterus | 100% | 2677.22 | 170 / 170 | 100% | 54.38 | 459 / 459 |
esophagus | 100% | 3241.01 | 1444 / 1445 | 100% | 77.40 | 183 / 183 |
brain | 100% | 4289.48 | 2637 / 2642 | 100% | 37.62 | 704 / 705 |
intestine | 100% | 3778.59 | 966 / 966 | 99% | 82.96 | 524 / 527 |
bladder | 100% | 3750.29 | 21 / 21 | 99% | 55.14 | 501 / 504 |
prostate | 100% | 3471.29 | 245 / 245 | 99% | 48.01 | 498 / 502 |
skin | 100% | 3175.53 | 1803 / 1809 | 99% | 38.06 | 469 / 472 |
lung | 99% | 3987.49 | 574 / 578 | 100% | 48.00 | 1151 / 1155 |
breast | 100% | 3175.21 | 459 / 459 | 98% | 42.29 | 1101 / 1118 |
kidney | 100% | 7514.54 | 89 / 89 | 98% | 34.68 | 881 / 901 |
pancreas | 99% | 2132.83 | 326 / 328 | 98% | 33.94 | 175 / 178 |
thymus | 100% | 3359.59 | 652 / 653 | 95% | 22.64 | 576 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 53.30 | 29 / 29 |
spleen | 100% | 2954.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.20 | 1 / 1 |
adipose | 100% | 3607.17 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2557.24 | 1325 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2588.67 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 3905.37 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 23.36 | 75 / 80 |
peripheral blood | 56% | 2851.90 | 519 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0006986 | Biological process | response to unfolded protein |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005739 | Cellular component | mitochondrion |
GO_0016020 | Cellular component | membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HSPE1 |
Protein name | Heat shock 10kDa protein 1 (Chaperonin 10), isoform CRA_h (Heat shock protein family E (Hsp10) member 1) 10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF) 10 kDa heat shock protein, mitochondrial (10 kDa chaperonin) (Chaperonin 10) |
Synonyms | hCG_21429 |
Description | FUNCTION: Co-chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp60, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix . The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable). . |
Accessions | ENST00000409729.1 ENST00000233893.10 ENST00000409468.1 B8ZZ54 B8ZZL8 P61604 |